Australian Labor Party plans to invest USD 53 million on PrEP drug

Date: 2017-12-12   Author: Saipriya Iyer  Category: #market

Australian Labor Party plans to invest USD 53 million on PrEP drug

The Labor Opposition in Australia has unveiled its plans to invest nearly USD 53 million for conducting more clinical trials on PrEP, an effective medicine endowed with the ability to prevent HIV contraction. According to reliable sources, the plan encompasses a funding of USD 3.6 million for states to increase the tests on PrEP, also referred as Truvada, for avoiding HIV. Spokespersons of the opposition Labor party have claimed that the medicine will be made easily available for additional 17,500 persons at a drastically reduced drug price of USD 6.30 from USD 1200.

It has been forecast that the funds will also be utilized for carrying out PrEP trials in the northern region of Australia to effectively handle the rising rates of HIV transmission in Aboriginal communities & the Torret Strait Islander population. The strategic move apparently, has also been predicted to address the rise in the transmission of HIV cases in the indigenous population of Australia.

In a bid to make HIV history in the country, the spokeswoman of the labor party in Australia, Catherine King, has declared the party’s goal to reduce the number of HIV cases from 1000 to zero per year, intending to make Australia the first nation to eliminate the virus. King has also stated that people susceptible to HIV infections would be provided with the preventive drug at affordable costs under the party’s federal plan.

According to healthcare experts, the drug is highly popular among the gay community owing to its ability to reduce transmissions. It has been predicted that the medicine has proved to be ninety-nine percent effective in avoiding HIV infection. Industry analysts are of the view that the new labor plan will provide widespread access to the highly effective drug and ease its delivery to communities who are at a higher risk of getting infected with HIV. They have also claimed that the plan will help in saving nearly USD 2 billion of total public health costs.

About Author

Saipriya Iyer linkdin-boxtwitter

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

Post Recommendents

Antenatal Screening Market Share, By Product Analysis, Application, End-Use, Regional Outlook, Competitive Strategies & Forecast up to 2028

Author: Ashwin Naphade

Global Antenatal Screening Market, 2022-2028 Research Report provides crucial statistics on the market status of the Global Antenatal Screening manufacturers and is a respected source of guidance and direction for companies and individuals interes...

Pediatric Vitrectomy Market Size | Global Industry Analysis, Segments, Top Key Players, Drivers and Trends to 2028

Author: Ashwin Naphade

Global Pediatric Vitrectomy market report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

The Pediatric Vitrectomy market repor...

Legionnaire Disease Testing Market Comprehensive Analysis, Share, Growth Forecast from 2022 to 2028c

Author: Ashwin Naphade

This report studies the Global Legionnaire Disease Testing market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, ...